All patient guidesSemua panduan pasien返回全部指南
March 04, 2026 Patient guidePanduan pasien就医指南

Cancer Treatment in China: Comparing Beijing, Shanghai, Guangzhou, and Shenzhen for International PatientsCancer Treatment in China: Comparing Beijing, Shanghai, Guangzhou, and Shenzhen for International Patients中国癌症治疗:国际患者在北京、上海、广州和深圳的比较

China has risen as a leading destination for oncology medical tourism, with Beijing, Shanghai, Guangzhou, and Shenzhen standing out for their world-class facilities, innovative therapies, and affordability—often 40-80% less than in the US o…China has risen as a leading destination for oncology medical tourism, with Beijing, Shanghai, Guangzhou, and Shenzhen standing out for their world-class facilities, innovative therapies, and affordability—often 40-80% less than in the US o…中国已成为肿瘤医学旅游的主要目的地,北京、上海、广州和深圳因其世界级的设施、创新疗法和经济实惠而脱颖而出——通常比美国或欧洲低40-80%。每个城市都有独特的优势:北京以权威的国家中心著称,上海以精准放疗闻名,广州专注于区域特色,深圳则以跨境效率见长。到2026年,这些中心提供临床试验、多学科团队和国际服务,使其对面临高费用或等待时间的外国患者具有吸引力。

China has risen as a leading destination for oncology medical tourism, with Beijing, Shanghai, Guangzhou, and Shenzhen standing out for their world-class facilities, innovative therapies, and affordability—often 40-80% less than in the US or Europe. Each city has unique strengths: Beijing for authoritative national centers, Shanghai for precision radiation, Guangzhou for regional specialties, and Shenzhen for cross-border efficiency. In 2026, these hubs provide access to clinical trials, multidisciplinary teams, and international services, making them attractive for foreigners facing high costs or waits at home.

This comparative guide outlines key hospitals, treatment capabilities, estimated costs, and factors to consider, helping you choose based on your cancer type, needs, and preferences.

Why International Patients Choose China for Cancer Care

Key draws include:

  • Quality and Innovation: Alignment with global standards (NCCN guidelines), large case volumes for expertise, and leadership in trials (China hosts ~39% globally).
  • Cost Savings: Comprehensive treatments at fractions of Western prices, with domestic drugs reducing expenses.
  • Rapid Access: Shorter waits, often days for consultations and procedures.
  • International Focus: English/multilingual support, JCI-accredited options, visa invitations, and insurance billing (Cigna, Allianz, Bupa).
  • City-Specific Perks: Proximity to regions (e.g., Shenzhen near Hong Kong) and integrative TCM for side-effect management.

Patients often select based on cancer type: e.g., rare tumors in Beijing, radiation-resistant in Shanghai.

At-a-Glance Comparison

Factor Beijing Shanghai Guangzhou Shenzhen
Strengths National authority, rare/complex tumors, full-spectrum care Precision radiation (proton/heavy ion), international standards Regional cancers (NPC, liver), minimally invasive interventions Cross-border convenience, innovation/tech integration
Top Hospitals CAMS Cancer Hospital, Peking University Cancer Hospital FUSCC, SPHIC, Jiahui International SYSUCC, Fuda Cancer Hospital CAMS Shenzhen, HKU-Shenzhen Hospital
Key Technologies MDT, CAR-T, robotic surgery Proton/carbon ion, NGS sequencing Cryosurgery, NanoKnife, TACE AI diagnostics, CAR-T trials, proton therapy
Cost Level (USD) Medium-High ($10K–$50K+ for comprehensive) High ($15K–$60K+ due to advanced tech) Medium-Low ($8K–$40K, cost-effective) Medium ($10K–$45K, efficient)
International Friendliness Good (English in public intl. depts.) Excellent (JCI-accredited privates) Very Good (multilingual, tourism-friendly) Excellent (HK integration, English teams)
Best For Doubtful/rare cases, clinical trials Radiation-resistant tumors, holistic care NPC/liver cancer, non-surgical options Southeast Asia/HK patients, quick access

Detailed City Overviews

Beijing: The National Powerhouse

As China's academic center, Beijing excels in authoritative, research-driven care for all cancer types.

  • Leading Hospitals: Chinese Academy of Medical Sciences Cancer Hospital (National Cancer Center), Peking University Cancer Hospital, Peking Union Medical College Hospital.
  • Treatment Capabilities: Full-spectrum MDT, precision medicine (NGS), robotic surgery, CAR-T (blood/solid tumors), advanced radiotherapy (IMRT/SBRT), immunotherapy (PD-1), and extensive trials. Strengths in lung, breast, colorectal, and rare tumors.
  • Estimated Costs (USD): Diagnostics: $2K–$6K; Surgery: $5K–$30K; Chemo cycle: $500–$3K; Radiotherapy: $5K–$25K; Immunotherapy monthly: $2K–$8K; Overall early-stage: $7K–$21K; Advanced annual: $7K–$21K+.
  • International Aspects: English support in intl. depts., visa letters, but public hospitals can be crowded—opt for VIP wards.

Shanghai: The Tech and International Leader

Shanghai emphasizes precision and global standards, with top radiation tech and foreigner-friendly services.

  • Leading Hospitals: Fudan University Shanghai Cancer Center (FUSCC), Shanghai Proton and Heavy Ion Center (SPHIC), Jiahui International Cancer Center (JCI-accredited).
  • Treatment Capabilities: Proton/carbon ion therapy (90%+ control for certain tumors), MDT, NGS/molecular subtyping, robotic/minimally invasive surgery, CAR-T, immunotherapy combinations, and integrative TCM. Excels in breast, pancreatic, gastrointestinal, and radiation-resistant cases (e.g., brain/prostate).
  • Estimated Costs (USD): Diagnostics: $2K–$6K; Surgery: $5K–$35K; Chemo cycle: $600–$3.5K; Radiotherapy (standard): $6K–$18K; Proton: $40K–$70K; Immunotherapy monthly: $2.5K–$9K; Overall early-stage: $8K–$25K; Advanced annual: $10K–$30K+.
  • International Aspects: JCI-level care, full English teams, direct billing, and cosmopolitan environment—ideal for Western-style experiences.

Guangzhou: The Cost-Effective Regional Specialist

Guangzhou focuses on Southern-high-incidence cancers with innovative, minimally invasive options and value.

  • Leading Hospitals: Sun Yat-sen University Cancer Center (SYSUCC), Fuda Cancer Hospital (JCI-accredited), St. Stamford Modern Cancer Hospital.
  • Treatment Capabilities: MDT, cryosurgery/NanoKnife for inoperable tumors, interventional (TACE/seed implantation), CAR-T, hyperthermia-enhanced immunotherapy, and TCM integration. Leaders in nasopharyngeal carcinoma (NPC), liver, lung, and digestive cancers.
  • Estimated Costs (USD): Diagnostics: $1.5K–$5K; Surgery: $5K–$20K; Chemo cycle: $500–$3K; Radiotherapy: $4K–$15K; Minimally invasive: $5K–$30K; Immunotherapy monthly: $2K–$7K; Overall early-stage: $7K–$20K; Advanced annual: $8K–$25K+.
  • International Aspects: Multilingual (Arabic, Russian, Indonesian), tourism-friendly with lower living costs, and experience with diverse patients.

Shenzhen: The Efficient Cross-Border Hub

Shenzhen offers tech-driven care with seamless Hong Kong integration, suited for quick, innovative treatments.

  • Leading Hospitals: Cancer Hospital CAMS Shenzhen Center, University of Hong Kong-Shenzhen Hospital (HKU-Shenzhen), Southern University of Science and Technology Hospital.
  • Treatment Capabilities: AI-assisted diagnostics, proton therapy, CAR-T (blood/solid), robotic surgery, NGS sequencing, and MDT with "chemo-free" options. Strong in lung, colorectal, liver, and hematologic cancers, with rapid trial access.
  • Estimated Costs (USD): Diagnostics: $1.5K–$5K; Surgery: $5K–$25K; Chemo cycle: $500–$3K; Radiotherapy: $5K–$12K; Proton: $30K–$50K; Immunotherapy monthly: $2K–$6K; Overall early-stage: $7K–$18K; Advanced annual: $8K–$20K+.
  • International Aspects: English/HK-style management, high-speed rail to Hong Kong for drug access, and efficient processes—great for Southeast Asian patients.

Practical Advice for Foreign Patients

  • Choosing a City: Beijing for complex/rare; Shanghai for advanced radiation/international comfort; Guangzhou for NPC/liver/value; Shenzhen for speed/cross-border.
  • Preparation: Translate records, secure medical (S2) visas with invitations, confirm insurance.
  • Costs Considerations: Factor in hospital stays ($20–$500/day), accommodation ($50–$150/night), and trials for savings. Upfront deposits common.
  • General Tips: Use intl. depts. for language/logistics, explore TCM for support, and plan telemedicine follow-ups.

China provides high-quality, innovative cancer care across these cities. Consult hospitals for personalized plans. Best wishes for your health.

China has risen as a leading destination for oncology medical tourism, with Beijing, Shanghai, Guangzhou, and Shenzhen standing out for their world-class facilities, innovative therapies, and affordability—often 40-80% less than in the US or Europe. Each city has unique strengths: Beijing for authoritative national centers, Shanghai for precision radiation, Guangzhou for regional specialties, and Shenzhen for cross-border efficiency. In 2026, these hubs provide access to clinical trials, multidisciplinary teams, and international services, making them attractive for foreigners facing high costs or waits at home.

This comparative guide outlines key hospitals, treatment capabilities, estimated costs, and factors to consider, helping you choose based on your cancer type, needs, and preferences.

Why International Patients Choose China for Cancer Care

Key draws include:

  • Quality and Innovation: Alignment with global standards (NCCN guidelines), large case volumes for expertise, and leadership in trials (China hosts ~39% globally).
  • Cost Savings: Comprehensive treatments at fractions of Western prices, with domestic drugs reducing expenses.
  • Rapid Access: Shorter waits, often days for consultations and procedures.
  • International Focus: English/multilingual support, JCI-accredited options, visa invitations, and insurance billing (Cigna, Allianz, Bupa).
  • City-Specific Perks: Proximity to regions (e.g., Shenzhen near Hong Kong) and integrative TCM for side-effect management.

Patients often select based on cancer type: e.g., rare tumors in Beijing, radiation-resistant in Shanghai.

At-a-Glance Comparison

Factor Beijing Shanghai Guangzhou Shenzhen
Strengths National authority, rare/complex tumors, full-spectrum care Precision radiation (proton/heavy ion), international standards Regional cancers (NPC, liver), minimally invasive interventions Cross-border convenience, innovation/tech integration
Top Hospitals CAMS Cancer Hospital, Peking University Cancer Hospital FUSCC, SPHIC, Jiahui International SYSUCC, Fuda Cancer Hospital CAMS Shenzhen, HKU-Shenzhen Hospital
Key Technologies MDT, CAR-T, robotic surgery Proton/carbon ion, NGS sequencing Cryosurgery, NanoKnife, TACE AI diagnostics, CAR-T trials, proton therapy
Cost Level (USD) Medium-High ($10K–$50K+ for comprehensive) High ($15K–$60K+ due to advanced tech) Medium-Low ($8K–$40K, cost-effective) Medium ($10K–$45K, efficient)
International Friendliness Good (English in public intl. depts.) Excellent (JCI-accredited privates) Very Good (multilingual, tourism-friendly) Excellent (HK integration, English teams)
Best For Doubtful/rare cases, clinical trials Radiation-resistant tumors, holistic care NPC/liver cancer, non-surgical options Southeast Asia/HK patients, quick access

Detailed City Overviews

Beijing: The National Powerhouse

As China's academic center, Beijing excels in authoritative, research-driven care for all cancer types.

  • Leading Hospitals: Chinese Academy of Medical Sciences Cancer Hospital (National Cancer Center), Peking University Cancer Hospital, Peking Union Medical College Hospital.
  • Treatment Capabilities: Full-spectrum MDT, precision medicine (NGS), robotic surgery, CAR-T (blood/solid tumors), advanced radiotherapy (IMRT/SBRT), immunotherapy (PD-1), and extensive trials. Strengths in lung, breast, colorectal, and rare tumors.
  • Estimated Costs (USD): Diagnostics: $2K–$6K; Surgery: $5K–$30K; Chemo cycle: $500–$3K; Radiotherapy: $5K–$25K; Immunotherapy monthly: $2K–$8K; Overall early-stage: $7K–$21K; Advanced annual: $7K–$21K+.
  • International Aspects: English support in intl. depts., visa letters, but public hospitals can be crowded—opt for VIP wards.

Shanghai: The Tech and International Leader

Shanghai emphasizes precision and global standards, with top radiation tech and foreigner-friendly services.

  • Leading Hospitals: Fudan University Shanghai Cancer Center (FUSCC), Shanghai Proton and Heavy Ion Center (SPHIC), Jiahui International Cancer Center (JCI-accredited).
  • Treatment Capabilities: Proton/carbon ion therapy (90%+ control for certain tumors), MDT, NGS/molecular subtyping, robotic/minimally invasive surgery, CAR-T, immunotherapy combinations, and integrative TCM. Excels in breast, pancreatic, gastrointestinal, and radiation-resistant cases (e.g., brain/prostate).
  • Estimated Costs (USD): Diagnostics: $2K–$6K; Surgery: $5K–$35K; Chemo cycle: $600–$3.5K; Radiotherapy (standard): $6K–$18K; Proton: $40K–$70K; Immunotherapy monthly: $2.5K–$9K; Overall early-stage: $8K–$25K; Advanced annual: $10K–$30K+.
  • International Aspects: JCI-level care, full English teams, direct billing, and cosmopolitan environment—ideal for Western-style experiences.

Guangzhou: The Cost-Effective Regional Specialist

Guangzhou focuses on Southern-high-incidence cancers with innovative, minimally invasive options and value.

  • Leading Hospitals: Sun Yat-sen University Cancer Center (SYSUCC), Fuda Cancer Hospital (JCI-accredited), St. Stamford Modern Cancer Hospital.
  • Treatment Capabilities: MDT, cryosurgery/NanoKnife for inoperable tumors, interventional (TACE/seed implantation), CAR-T, hyperthermia-enhanced immunotherapy, and TCM integration. Leaders in nasopharyngeal carcinoma (NPC), liver, lung, and digestive cancers.
  • Estimated Costs (USD): Diagnostics: $1.5K–$5K; Surgery: $5K–$20K; Chemo cycle: $500–$3K; Radiotherapy: $4K–$15K; Minimally invasive: $5K–$30K; Immunotherapy monthly: $2K–$7K; Overall early-stage: $7K–$20K; Advanced annual: $8K–$25K+.
  • International Aspects: Multilingual (Arabic, Russian, Indonesian), tourism-friendly with lower living costs, and experience with diverse patients.

Shenzhen: The Efficient Cross-Border Hub

Shenzhen offers tech-driven care with seamless Hong Kong integration, suited for quick, innovative treatments.

  • Leading Hospitals: Cancer Hospital CAMS Shenzhen Center, University of Hong Kong-Shenzhen Hospital (HKU-Shenzhen), Southern University of Science and Technology Hospital.
  • Treatment Capabilities: AI-assisted diagnostics, proton therapy, CAR-T (blood/solid), robotic surgery, NGS sequencing, and MDT with "chemo-free" options. Strong in lung, colorectal, liver, and hematologic cancers, with rapid trial access.
  • Estimated Costs (USD): Diagnostics: $1.5K–$5K; Surgery: $5K–$25K; Chemo cycle: $500–$3K; Radiotherapy: $5K–$12K; Proton: $30K–$50K; Immunotherapy monthly: $2K–$6K; Overall early-stage: $7K–$18K; Advanced annual: $8K–$20K+.
  • International Aspects: English/HK-style management, high-speed rail to Hong Kong for drug access, and efficient processes—great for Southeast Asian patients.

Practical Advice for Foreign Patients

  • Choosing a City: Beijing for complex/rare; Shanghai for advanced radiation/international comfort; Guangzhou for NPC/liver/value; Shenzhen for speed/cross-border.
  • Preparation: Translate records, secure medical (S2) visas with invitations, confirm insurance.
  • Costs Considerations: Factor in hospital stays ($20–$500/day), accommodation ($50–$150/night), and trials for savings. Upfront deposits common.
  • General Tips: Use intl. depts. for language/logistics, explore TCM for support, and plan telemedicine follow-ups.

China provides high-quality, innovative cancer care across these cities. Consult hospitals for personalized plans. Best wishes for your health.

中国已成为肿瘤医学旅游的主要目的地,北京、上海、广州和深圳因其世界级的设施、创新疗法和经济实惠而脱颖而出——通常比美国或欧洲低40-80%。每个城市都有独特的优势:北京以权威的国家中心著称,上海以精准放疗闻名,广州专注于区域特色,深圳则以跨境效率见长。到2026年,这些中心提供临床试验、多学科团队和国际服务,使其对面临高费用或等待时间的外国患者具有吸引力。

本比较指南概述了关键医院、治疗能力、估计费用和考虑因素,帮助您根据癌症类型、需求和偏好进行选择。

为什么国际患者选择中国进行癌症治疗

主要吸引力包括:

  • 质量与创新:与全球标准(NCCN指南)对齐,病例量大以积累专业知识,试验领导地位(中国占全球约39%)。
  • 成本节省:全面治疗费用仅为西方价格的一部分,国内药物降低了开支。
  • 快速获取:等待时间较短,通常只需几天即可进行咨询和治疗。
  • 国际化关注:提供英语/多语言支持,JCI认证的选择,签证邀请和保险结算(Cigna、Allianz、Bupa)。
  • 城市特定优势:靠近区域(例如,深圳靠近香港)和整合中医以管理副作用。

患者通常根据癌症类型进行选择:例如,北京的罕见肿瘤,上海的放射抗性肿瘤。

一目了然的比较

因素 北京 上海 广州 深圳
优势 国家权威,罕见/复杂肿瘤,全方位护理 精准放疗(质子/重离子),国际标准 区域癌症(鼻咽癌、肝癌),微创干预 跨境便利,创新/技术整合
顶级医院 中国医学科学院肿瘤医院,北大肿瘤医院 复旦大学上海癌症中心,上海质子重离子中心,嘉会国际癌症中心 中山大学肿瘤医院,复大肿瘤医院 中国医学科学院深圳医院,香港大学深圳医院
关键技术 MDT,CAR-T,机器人手术 质子/碳离子,NGS测序 冷冻手术,NanoKnife,TACE AI诊断,CAR-T试验,质子治疗
费用水平(美元) 中高($10K–$50K+,全面治疗) 高($15K–$60K+,因先进技术) 中低($8K–$40K,性价比高) 中($10K–$45K,效率高)
国际友好度 良好(公共国际部门有英语) 优秀(JCI认证的私立医院) 非常好(多语言,旅游友好) 优秀(与香港整合,英语团队)
最佳适合 疑难/罕见病例,临床试验 放射抗性肿瘤,整体护理 鼻咽癌/肝癌,非手术选项 东南亚/香港患者,快速获取

城市详细概述

北京:国家强国

作为中国的学术中心,北京在所有癌症类型的权威、研究驱动的护理方面表现出色。

  • 领先医院:中国医学科学院肿瘤医院(国家癌症中心),北大肿瘤医院,北方联合医学学院医院。
  • 治疗能力:全方位MDT,精准医学(NGS),机器人手术,CAR-T(血液/实体肿瘤),先进放疗(IMRT/SBRT),免疫治疗(PD-1)和广泛的临床试验。对肺癌、乳腺癌、结直肠癌和罕见肿瘤有优势。
  • 估计费用(美元):诊断:$2K–$6K;手术:$5K–$30K;化疗周期:$500–$3K;放疗:$5K–$25K;免疫治疗每月:$2K–$8K;整体早期:$7K–$21K;晚期年度:$7K–$21K+。
  • 国际方面:国际部门提供英语支持,签证信,但公立医院可能人满为患——建议选择VIP病房。

上海:科技与国际领导者

上海强调精准和全球标准,拥有顶级放疗技术和外国友好的服务。

  • 领先医院:复旦大学上海癌症中心(FUSCC),上海质子重离子中心(SPHIC),嘉会国际癌症中心(JCI认证)。
  • 治疗能力:质子/碳离子治疗(对某些肿瘤控制率超过90%),MDT,NGS/分子分型,机器人/微创手术,CAR-T,免疫治疗组合和整合中医。在乳腺癌、胰腺癌、胃肠癌和放射抗性病例(例如,脑癌/前列腺癌)方面表现出色。
  • 估计费用(美元):诊断:$2K–$6K;手术:$5K–$35K;化疗周期:$600–$3.5K;放疗(标准):$6K–$18K;质子:$40K–$70K;免疫治疗每月:$2.5K–$9K;整体早期:$8K–$25K;晚期年度:$10K–$30K+。
  • 国际方面:JCI级护理,完整的英语团队,直接结算,国际化环境——非常适合西方风格的体验。

广州:性价比高的区域专家

广州专注于南方高发癌症,提供创新的微创选项和价值。

  • 领先医院:中山大学肿瘤医院(SYSUCC),复大肿瘤医院(JCI认证),圣斯坦福现代癌症医院。
  • 治疗能力:MDT,冷冻手术/NanoKnife用于不可手术肿瘤,介入(TACE/种子植入),CAR-T,热疗增强免疫治疗和中医整合。在鼻咽癌(NPC)、肝癌、肺癌和消化道癌症方面处于领先地位。
  • 估计费用(美元):诊断:$1.5K–$5K;手术:$5K–$20K;化疗周期:$500–$3K;放疗:$4K–$15K;微创:$5K–$30K;免疫治疗每月:$2K–$7K;整体早期:$7K–$20K;晚期年度:$8K–$25K+。
  • 国际方面:多语言(阿拉伯语、俄语、印尼语),旅游友好,生活成本较低,具有多样化患者的经验。

深圳:高效的跨境中心

深圳提供技术驱动的护理,与香港无缝整合,适合快速、创新的治疗。

  • 领先医院:中国医学科学院深圳医院,香港大学深圳医院(HKU-Shenzhen),南方科技大学医院。
  • 治疗能力:AI辅助诊断,质子治疗,CAR-T(血液/实体),机器人手术,NGS测序和MDT与“无化疗”选项。对肺癌、结直肠癌、肝癌和血液癌症表现强劲,快速进入临床试验。
  • 估计费用(美元):诊断:$1.5K–$5K;手术:$5K–$25K;化疗周期:$500–$3K;放疗:$5K–$12K;质子:$30K–$50K;免疫治疗每月:$2K–$6K;整体早期:$7K–$18K;晚期年度:$8K–$20K+。
  • 国际方面:英语/香港风格管理,高速铁路通往香港以获取药物,流程高效——非常适合东南亚患者。

外国患者的实用建议

  • 选择城市:北京适合复杂/罕见病例;上海适合先进放疗/国际舒适;广州适合鼻咽癌/肝癌/性价比;深圳适合快速/跨境。
  • 准备工作:翻译病历,确保医疗(S2)签证和邀请函,确认保险。
  • 费用考虑:考虑住院费用($20–$500/天)、住宿费用($50–$150/晚)和临床试验以节省开支。预付押金很常见。
  • 一般建议:使用国际部门处理语言/物流,探索中医以获得支持,计划远程医疗后续。

中国在这些城市提供高质量、创新的癌症护理。请咨询医院以获取个性化计划。祝您健康。

WhatsApp